Drug Profile


Alternative Names: Aipuliete™; ONO 9302; SKF 105657

Latest Information Update: 04 Dec 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Developer China Pharmaceutical University; Jiangsu Lianhuan Pharmaceutical; Ono Pharmaceutical
  • Class Androstadienes; Antihormones; Small molecules
  • Mechanism of Action Cholestenone 5-alpha reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Benign prostatic hyperplasia
  • Discontinued Acne; Alopecia; Cancer

Most Recent Events

  • 15 Apr 2000 Launched for Benign prostatic hyperplasia in China (unspecified route)
  • 23 Mar 1999 Discontinued-Preclinical for Acne in USA (Unknown route)
  • 23 Mar 1999 Discontinued-Preclinical for Alopecia in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top